Carmen Hidalgo

Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.

Manuel Ramos‐Casals, Francisco José García Hernández, E de Ramón et al. · PubMed · 2010 · 140 citations

Life Sciences, Internal Medicine, Pharmacotherapy +16

Analysis of a Functional BTNL2 Polymorphism in Type 1 Diabetes, Rheumatoid Arthritis, and Systemic Lupus Erythematosus

Gisela Orozco, Peter Eerligh, Elena Sánchez et al. · Human Immunology · 2005 · 77 citations

Life Sciences, Genetics, Molecular Genetics +12

Lowered Rilpivirine Exposure During the Third Trimester of Pregnancy in Human Immunodeficiency Virus Type 1–Infected Women

Stein Schalkwijk, Angela Colbers, Déborah Konopnicki et al. · Clinical Infectious Diseases · 2017 · 72 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label

Cándido Díaz‐Lagares, R. Pérez-Álvarez, Francisco José García Hernández et al. · Arthritis Research & Therapy · 2011 · 71 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +9

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

A Howe, Chaturaka Rodrigo, Evan B. Cunningham et al. · JHEP Reports · 2022 · 42 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +16